Item 1. Financial Statements
Item
1. Financial Statements.
Barfresh
Food Group Inc.
Condensed
Consolidated Balance Sheets
September 30,
December 31,
2025
2024
(unaudited)
(audited)
Assets
Current assets:
Cash
$ 1,891,000
$ 235,000
Trade accounts receivable, net
2,489,000
829,000
Other receivables
62,000
55,000
Inventory, net
1,074,000
1,500,000
Prepaid expenses and other current assets
155,000
104,000
Total current assets
5,671,000
2,723,000
Property, plant and equipment, net of depreciation
697,000
333,000
Intangible assets, net of amortization
125,000
178,000
Other non-current assets
302,000
84,000
Total assets
$ 6,795,000
$ 3,318,000
Liabilities and Stockholders’ Equity
Current liabilities:
Line of credit
$ 1,736,000
$ 609,000
Accounts payable
1,729,000
1,200,000
Disputed co-manufacturer accounts payable (Note 4)
499,000
499,000
Accrued expenses
222,000
142,000
Accrued payroll and employee related expenses
92,000
67,000
Financing agreements - current
266,000
99,000
Total current liabilities
4,544,000
2,616,000
Financing agreements
330,000
124,000
Total liabilities
4,874,000
2,740,000
Commitments and contingencies
-
-
Stockholders’ equity:
Preferred stock, $ 0.000001 par value, 400,000 shares authorized, none issued or outstanding
-
-
Common stock, $ 0.000001 par value; 23,000,000 shares authorized; and 15,940,261 and 14,746,172 shares issued and outstanding at September 30, 2025 and December 31, 2024, respectively
-
-
Additional paid in capital
67,473,000
64,199,000
Accumulated deficit
( 65,552,000 )
( 63,621,000 )
Total stockholders’ equity
1,921,000
578,000
Total liabilities and stockholders’ equity
$ 6,795,000
$ 3,318,000
See
the accompanying notes to the condensed consolidated financial statements
3
Barfresh
Food Group Inc.
Condensed
Consolidated Statements of Operations
For
the three and nine months ended September 30, 2025 and 2024
(Unaudited)
2025
2024
2025
2024
For the three months ended September 30,
For the nine months ended September 30,
2025
2024
2025
2024
Revenue
$ 4,231,000
$ 3,637,000
$ 8,786,000
$ 7,929,000
Cost of revenue
2,679,000
2,377,000
5,828,000
4,991,000
Gross profit
1,552,000
1,260,000
2,958,000
2,938,000
Operating expenses:
Selling, marketing and distribution
941,000
990,000
2,399,000
2,267,000
General and administrative
844,000
705,000
2,264,000
2,423,000
Depreciation and amortization
27,000
65,000
161,000
197,000
Total operating expenses
1,812,000
1,760,000
4,824,000
4,887,000
Loss from operations
( 260,000 )
( 500,000 )
( 1,866,000 )
( 1,949,000 )
Interest expense
30,000
13,000
65,000
24,000
Net loss
$ ( 290,000 )
$ ( 513,000 )
$ ( 1,931,000 )
$ ( 1,973,000 )
Per share information - basic and fully diluted:
Weighted average shares outstanding
15,940,000
14,744,000
15,750,000
14,655,000
Net loss per share
$ ( 0.02 )
$ ( 0.03 )
$ ( 0.12 )
$ ( 0.13 )
See
the accompanying notes to the condensed consolidated financial statements
4
Barfresh
Food Group Inc.
Condensed
Consolidated Statements of Cash Flows
For
the nine months ended September 30, 2025 and 2024
(Unaudited)
2025
2024
Net loss
$ ( 1,931,000 )
$ ( 1,973,000 )
Adjustments to reconcile net loss to net cash used in operating activities
Stock-based compensation
461,000
757,000
Depreciation and amortization
185,000
217,000
Amortization of debt discount
( 12,000 )
17,000
Changes in assets and liabilities
Accounts receivable
( 1,660,000 )
( 842,000 )
Other receivables
( 7,000 )
130,000
Inventories
426,000
444,000
Prepaid expenses and other assets
( 269,000 )
( 95,000 )
Accounts payable
529,000
( 379,000 )
Accrued expenses
105,000
180,000
Net cash used in operating activities
( 2,173,000 )
( 1,544,000 )
Investing activities
Purchase of property and equipment
( 42,000 )
( 61,000 )
Net cash used in investing activities
( 42,000 )
( 61,000 )
Financing activities
Borrowings under line of credit
4,389,000
930,000
Repayment of line of credit
( 3,250,000 )
( 847,000 )
Issuance of convertible debt
-
65,000
Financing agreement payments
( 81,000 )
( 13,000 )
Issuance of common stock, net of $ 26,000 issuance cost
2,974,000
-
Shares repurchased for income tax withholding under stock compensation program
( 161,000 )
( 20,000 )
Net cash provided by financing activities
3,871,000
115,000
Net increase (decrease) in cash
1,656,000
( 1,490,000 )
Cash, beginning of period
235,000
1,891,000
Cash, end of period
$ 1,891,000
$ 401,000
Non-cash financing and investing activities:
Financed acquisition of long-term assets
$ 454,000
$ 245,000
Conversion of debt and interest to equity
$ -
$ 136,000
Convertible notes issued in exchange for trade payables
$ -
$ 71,000
Cash paid for interest
$ 53,000
$ 7,000
See
the accompanying notes to the condensed consolidated financial statements
5
Barfresh
Food Group Inc.
Notes
to Condensed Consolidated Financial Statements
September
30, 2025
(Unaudited)
Note
1. Description of the Business, Basis of Presentation, and Summary of Significant Accounting Policies
Barfresh
Food Group Inc., (“we,” “us,” “our,” and the “Company”) was incorporated on February
25, 2010 in the State of Delaware. The Company is engaged in the manufacturing and distribution of ready-to-drink and ready-to-blend
beverages, particularly, smoothies, shakes and frappes.
Basis
of Presentation
The
accompanying condensed consolidated financial statements are unaudited. These unaudited interim condensed consolidated financial statements
have been prepared in conformity with accounting principles generally accepted in the United States of America (“GAAP”) and
applicable rules and regulations of the U.S. Securities and Exchange Commission (“SEC”) regarding interim financial reporting.
Certain information and footnote disclosures normally included in the financial statements prepared in accordance with GAAP have been
condensed or omitted pursuant to such rules and regulations. Accordingly, these interim condensed consolidated financial statements should
be read in conjunction with the audited consolidated financial statements for the fiscal year ended December 31, 2024 included in the
Company’s Annual Report on Form 10-K, as filed with the SEC on March 27, 2025. In management’s opinion, the unaudited interim
condensed consolidated financial statements reflect all adjustments, which are of a normal and recurring nature, that are necessary for
a fair presentation of financial results for the interim periods presented. Operating results for any quarter are not necessarily indicative
of the results for the full fiscal year.
Principles
of Consolidation
The
consolidated financial statements include the financial statements of the Company and our wholly owned subsidiaries, Barfresh Inc. and
Barfresh Corporation Inc. (formerly known as Smoothie, Inc.). All inter-company balances and transactions among the companies have been
eliminated upon consolidation.
Use
of Estimates
The
preparation of financial statements in accordance with GAAP requires management to make estimates and assumptions that affect the reported
amounts of assets and liabilities in the balance sheets and revenues and expenses during the years reported. Actual results may differ
from these estimates.
Vendor
Concentrations
The
Company is exposed to supply risk as a result of concentration in its vendor base resulting from the use of a limited number of contract
manufacturers. Purchases from the Company’s significant contract manufacturers as a percentage of all finished goods purchased
were as follows:
Schedule of Contract Manufacturers Percentage of Finished Goods
2025
2024
2025
2024
For the three months ended September 30,
For the nine months ended September 30,
2025
2024
2025
2024
Manufacturer A
36 %
63 %
44 %
58 %
Manufacturer B
40 %
37 %
41 %
40 %
Other Manufacturers
24 %
0 %
15 %
2 %
Concentration percentage
24 %
0 %
15 %
2 %
Manufacturer
A has notified the Company that it will cease supplying smoothie bottles in February 2026. Manufacturer B, which makes
smoothie cartons, is currently installing bottling equipment which is expected to be operational in January 2026 with approximately
400% additional capacity of bottles over Manufacturer A. Manufacturer B will discontinue making smoothie cartons in December 2025 in
preparation for the transition to bottles. The Company’s acquisition of Arps (Note 8) is expected to mitigate supply risks
associated with co-manufacturing arrangements.
6
Summary
of Significant Accounting Policies
There
have been no changes to our significant accounting policies described in our Annual Report on Form 10-K for the year ended December 31,
2024, as filed with the SEC on March 27, 2025 that have had a material impact on our condensed consolidated financial statements and
related notes.
Financial
Instruments
The
Company’s financial instruments consist of cash, accounts receivable and accounts payable. The carrying value of the Company’s
financial instruments approximates their fair value.
Accounts
Receivable and Allowances
Accounts
receivable are recorded and carried at the original invoiced amount less allowances for credits and for any potential uncollectible amounts
due to credit losses. We make estimates of the expected credit and collectability trends for the allowance for credit losses based on
our assessment of various factors, including historical experience, the age of the accounts receivable balances, credit quality of our
customers, current economic conditions, and other factors that may affect our ability to collect from our customers. Expected credit
losses are recorded as general and administrative expenses on our condensed consolidated statements of operations. As of September 30,
2025 and December 31, 2024, there was no allowance for credit losses. There was no credit loss expense for the three and nine months
ended September 30, 2025 and 2024.
Revenue
Recognition
In
accordance with ASC 606, Revenue from Contracts with Customers, revenue is recognized when a customer obtains ownership of promised goods.
The amount of revenue recognized reflects the consideration to which the Company expects to be entitled to receive in exchange for these
goods. The Company applies the following five steps:
1)
Identify
the contract with a customer
A
contract with a customer exists when (i) the Company enters into an enforceable contract with a customer that defines each party’s
rights, (ii) the contract has commercial substance and, (iii) the Company determines that collection of substantially all consideration
for goods or services that are transferred is probable. For the Company, the contract is the approved sales order, which may also be
supplemented by other agreements that formalize various terms and conditions with customers.
2)
Identify
the performance obligation in the contract
Performance
obligations promised in a contract are identified based on the goods or services that will be transferred to the customer. For the Company,
this consists of the delivery of frozen beverages, which provide immediate benefit to the customer.
3)
Determine
the transaction price
The
transaction price is determined based on the consideration to which the Company will be entitled in exchange for transferring goods and
is generally stated on the approved sales order. Variable consideration, which typically includes rebates or discounts, are estimated
utilizing the most likely amount method. Provisions for refunds are generally provided for in the period the related sales are recorded,
based on management’s assessment of historical and projected trends.
4)
Allocate
the transaction price to performance obligations in the contract
Since
the Company’s contracts contain a single performance obligation, delivery of frozen beverages, the transaction price is allocated
to that single performance obligation.
7
5)
Recognize
revenue when or as the Company satisfies a performance obligation
The
Company recognizes revenue from the sale of frozen beverages when title and risk of loss passes and the customer accepts the goods, which
generally occurs at the time of delivery to a customer warehouse. Customer sales incentives such as volume-based rebates or discounts
are treated as a reduction of sales at the time the sale is recognized. Shipping and handling costs are treated as fulfilment costs and
presented in distribution, selling and administrative costs.
Payments
that are received before performance obligations are recorded are shown as current liabilities.
The
Company evaluated the requirement to disaggregate revenue and concluded that substantially all of its revenue comes from a single product,
frozen beverages.
Storage
and Shipping Costs
Storage
and outbound freight costs are included in selling, marketing and distribution expense. For the three months ending September 30, 2025
and 2024, storage and outbound freight totaled approximately $ 491,000 and $ 480,000 , respectively. For the nine months ended September
30, 2025 and 2024, storage and outbound freight totaled approximately $ 1,157,000 and $ 1,061,000 , respectively.
Research
and Development
Expenditures
for research activities relating to product development and improvement are charged to expense as incurred. The Company incurred approximately
$ 33,000 and $ 52,000 in research and development expense for the three months ended September 30, 2025 and 2024, respectively, and $ 82,000
and $ 99,000 for the nine months ended September 30, 2025 and 2024, respectively.
Loss
Per Share
For
the three and nine months ended September 30, 2025 and 2024, common stock equivalents have not been included in the calculation of net
loss per share as their effect is anti-dilutive as a result of losses incurred.
Recent
Pronouncements
From
time to time, new accounting pronouncements are issued that we adopt as of the specified effective date. We have not determined if the
impact of recently issued standards that are not yet effective will have an impact on our results of operations and financial position.
Note
2. Inventory
Inventory
consists of the following:
Schedule of Inventory
September 30,
December 31,
2025
2024
Raw materials and packaging
$ 680,000
$ 505,000
Finished goods
394,000
995,000
Inventory, net
$ 1,074,000
$ 1,500,000
8
Note
3. Property Plant and Equipment
Property
and equipment, net consist of the following:
Schedule of Property and Equipment, Net
September 30,
December 31,
2025
2024
Manufacturing equipment
$ 1,556,000
$ 1,376,000
Customer equipment
1,398,000
1,398,000
Construction in progress
468,000
152,000
Property and equipment, gross
3,422,000
2,926,000
Less: accumulated depreciation
( 2,725,000 )
( 2,593,000 )
Property and equipment, net of depreciation
$ 697,000
$ 333,000
Depreciation
expense related to these assets was approximately $ 24,000 and $ 55,000 for the three months ended September 30, 2025 and 2024, respectively,
and $ 132,000 and $ 168,000 for the nine months ended September 30, 2025 and 2024, respectively. Depreciation expense in cost of revenue
was $ 9,000 and $ 6,000 for the three months ended September 30, 2025 and 2024, respectively, and $ 25,000 and $ 19,000 for the nine months
ended September 30, 2025 and 2024, respectively.
Leased assets amounting to $ 454,000 are included in construction in progress at September 30, 2025.
Note
4. Commitments and Contingencies
Lease
Commitments
The
Company leases office space under a non-cancellable operating lease which expired on March
31, 2023 , and was extended
in a series of short-term amendments through March 31, 2026 . The Company’s periodic lease cost was approximately $ 20,000
for each of the three months ended September 30, 2025 and 2024 and $ 60,000
for each of the nine months ended September 30, 2025 and 2024.
Legal
Proceedings
Schreiber
Dispute
The
Company’s products are produced to its specifications through several contract manufacturers. One of the Company’s contract
manufacturers (the “Manufacturer”) provided approximately 52 % and 42 % of the Company’s products in the years ended
December 31, 2022 and 2021, respectively, under a Supply Agreement with an initial term through September 2025.
Over
the course of 2022, the Company experienced numerous quality issues with the case packaging utilized by the Manufacturer. In addition,
in July of 2022, the Company began receiving customer complaints about the texture of the Company’s smoothie products produced
by the Manufacturer. In response, the Company withdrew product from the market and destroyed on-hand inventory, withholding $ 499,000
in payments due to the Manufacturer.
The
Company attempted to resolve the issues based on the contractual procedures described in the Supply Agreement. However, on November 4,
2022, in response to a formal proposal of alternate resolutions, the Company received notification from the Manufacturer that it was
denying any responsibility for the defective manufacture of the product. In response, on November 10, 2022, the Company filed a complaint
in the United States District Court for the Central District of California, Western Division (the “Complaint”), claiming
that the Manufacturer had not met its obligations under the Supply Agreement, and seeking economic damages. In response, the Manufacturer
terminated the Supply Agreement. On January 20, 2023, the Company filed a voluntary dismissal of the Complaint which allowed the parties
to reach a potential resolution outside of the court system. However, as the parties were once again unable to come to an agreement,
the Company re-filed the Complaint in California State Court in August 2023 and continues to progress through the court system.
9
In
May 2024, the Company entered into a non-recourse litigation financing arrangement which is expected to be adequate to pursue the Complaint
to conclusion.
Due
to the uncertainties surrounding the claim, the Company is not able to predict either the outcome or a range of reasonably possible recoveries
that could result from its actions against the Manufacturer, and no gain contingencies have been recorded. The disruption in its supply
resulting from the dispute has adversely impacted the Company’s results of operations and cash flow. The Company has mitigated
the impact of the supply disruption with the introduction of its single-serve smoothie cartons, the identification of other co-manufacturing
sources, and the acquisition of Arps Dairy, Inc. (“Arps”), as described in Note 8.
Other
legal matters
From
time to time, various lawsuits and legal proceedings may arise in the ordinary course of business. However, litigation is subject to
inherent uncertainties and an adverse result in these or other matters may arise from time to time that may harm our business. We are
currently the defendant in one legal proceeding for an amount less than $ 100,000 . Our legal counsel and management believe the probability
of a material unfavorable outcome is remote.
Note
5. Debt
Line
of Credit
In
August 2024, the Company secured receivables financing of $ 1,500,000 (the “Facility”), and amended the facility in September
2025 to increase the available financing to $ 2,500,000 . Under the Facility, the Company may borrow up to 90% of eligible customer account
balances. Amounts outstanding bear interest at a rate prime plus 1.2% and collateral fees of 0.15% and are secured by accounts receivable
and inventory. The Facility expires on September 5, 2026, and renews automatically, unless notice is given or received. As of September
30, 2025, there was $ 1,759,000 drawn under the Facility, and $ 12,000 in unamortized discount.
Financing
Agreements
In
2024 and 2025, the Company entered into lease and financing agreements to purchase equipment and software as a service, with
weighted average imputed or stated interest of 24 %.
Amounts
due under the agreements are as follows as of September 30, 2025:
Schedule of Financing Agreements
2025 (3 months)
$ 92,000
2026
368,000
2027
312,000
Total payments due
772,000
Less: interest
( 176,000 )
Financing agreements
596,000
Less: current portion
( 266,000 )
Financing agreements
$ 330,000
Commitments under lease financing arrangements amounting
to $ 196,000 and $ 304,000 are included in financing agreements – current and financing agreements, respectively, at September 30,
2025.
Convertible
Notes
From
July 2023 to March 2024, the Company executed subscription agreements for substantially all of a $ 2,000,000 privately placed convertible
debt offering. The debt was available to be drawn in 25% increments, maturing on the anniversary of the draw, bearing interest at 10%
per annum for the term, regardless of earlier payment or conversion, and was mandatorily convertible as to principal and interest into
shares of the Company’s common stock at any time prior to maturity at the greater of $1.20 or 85% of the volume-weighted average
price of the common stock for the ten trading days immediately preceding the written notice of the conversion (the “Conversion
Price”). If the Company had not exercised the mandatory conversion, the holder of the debt had the option after six months and
on up to four occasions to convert all or any portion of the principal and interest into shares of the Company’s common stock at
the Conversion Price.
10
On
October 23, 2023, the Company drew down $ 1,390,000 in convertible debt and converted a total of $ 1,207,000 of principal into 820,160
shares of common stock. Additionally, on December 19, 2023, the Company drew down $ 470,000 in convertible debt and converted a total
of $ 653,000 of principal and $ 4,000 of accrued interest into 495,331 shares of common stock. Finally, on March 27 and 29, 2024 the Company
drew down $ 136,000 in convertible debt and converted the total drawn into 124,208 shares, settling all debt. Debt drawdowns included
the non-cash settlement of $ 30,000 and $ 71,000 in 2023 and 2024, respectively.
Note
6. Stockholders’ Equity
The
following are changes in stockholders’ equity for the nine months ended September 30, 2024 and 2025:
Schedule of Changes in Stockholders’ Equity
Shares
Amount
Capital
(Deficit)
Total
Common Stock
Additional
paid in
Accumulated
Shares
Amount
Capital
(Deficit)
Total
Balance December 31, 2023
14,420,105
$ -
$ 63,299,000
$ ( 60,796,000 )
$ 2,503,000
Issuance of common stock for equity compensation, net of shares repurchased for income tax withholding
201,859
-
( 20,000 )
-
( 20,000 )
Equity-based compensation expense
-
-
757,000
-
757,000
Conversion of debt and interest (Note 5)
124,208
-
136,000
-
136,000
Registered issuance of common stock
-
-
-
Net loss
-
-
-
( 1,973,000 )
( 1,973,000 )
Balance September 30, 2024
14,746,172
$ -
$ 64,172,000
$ ( 62,769,000 )
$ 1,403,000
Common Stock
Additional
paid in
Accumulated
Shares
Amount
Capital
(Deficit)
Total
Balance December 31, 2024
14,746,172
$ -
$ 64,199,000
$ ( 63,621,000 )
$ 578,000
Balance
14,746,172
$ -
$ 64,199,000
$ ( 63,621,000 )
$ 578,000
Issuance of common stock for equity compensation, net of shares repurchased for income tax withholding
141,296
-
( 161,000 )
-
( 161,000 )
Equity-based compensation expense
-
-
461,000
-
461,000
Registered issuance of common stock
1,052,793
2,974,000
2,974,000
Net loss
-
-
-
( 1,931,000 )
( 1,931,000 )
Balance September 30, 2025
15,940,261
$ -
$ 67,473,000
$ ( 65,552,000 )
$ 1,921,000
Balance
15,940,261
$ -
$ 67,473,000
$ ( 65,552,000 )
$ 1,921,000
On
February 5, 2025, the Company entered into securities purchase agreements with several investors, pursuant to which the Company sold
an aggregate of 1,052,793 shares of common stock at a price of $ 2.85 per share in a registered direct offering.
Warrants
There
are no warrants outstanding as of September 30, 2025.
Equity
Incentive Plan
As
of September 30, 2025, the Company has $ 514,000 of total unrecognized share-based compensation expense relative to unvested options,
stock awards and stock units, which is expected to be recognized over the remaining weighted average period of 2.2 years.
11
Stock
Options
The
following is a summary of stock option activity for the nine months ended September 30, 2025:
Schedule of Stock Options Activity
Number of
Options
Weighted
average
exercise price
per share
Remaining
term in years
Outstanding on December 31, 2024
710,323
$ 5.04
5.5
Issued
85,979
$ 2.72
Forfeited
-
Expired
( 35,223 )
$ 8.79
Outstanding on September 30, 2025
761,079
$ 4.60
5.5
Exercisable, September 30, 2025
534,978
$ 5.40
4.1
The
fair value of the options issued was calculated using the Black-Scholes option pricing model, based on the following:
Schedule of Fair Value of Options Using Black-Sholes Option Pricing Model
2025
Expected term (in years)
8.0
Expected volatility
97.9 %
Risk-free interest rate
4.2 %
Expected dividends
$ -
Weighted average grant date fair value per share
$ 2.26
Restricted
Stock
The
following is a summary of restricted stock award and restricted stock unit activity for the nine months ended
Schedule of Restricted Stock Award and Restricted Stock Unit Activity
Number of
shares
Weighted
average grant
date fair value
Unvested at January 1, 2025
61,873
$ 2.72
Granted
119,169
$ 2.62
Forfeited
( 24,960 )
$ 1.67
Vested
( 39,293 )
$ ( 3.67 )
Unvested at September 30, 2025
116,789
$ 2.45
12
Performance
Share Units
The
Company issues performance share units (“PSUs”) that represented shares potentially issuable based upon Company and individual
performance in the years of issuance.
The
following table summarizes the activity for the Company’s unvested PSUs for the nine months ended September 30, 2025:
Schedule of Performance Stock Unit Activity
Number of
shares
Weighted
average grant
date fair value
Unvested January 1, 2025
157,694
$ 1.20
Vested
( 155,157 )
$ 1.20
Issued
143,011
$ 2.74
Unvested at September 30, 2025
145,548
$ 2.70
Note
7. Income Taxes
ASC
740 requires a valuation allowance to reduce the deferred tax assets reported if, based on the weight of evidence, it is more than likely
than not that some portion or all the deferred tax assets will not be recognized. Accordingly, at this time the Company has placed a
valuation allowance on all tax assets. As of September 30, 2025, the estimated effective tax rate for 2025 was zero .
There
are open statutes of limitations for taxing authorities in federal and state jurisdictions to audit our tax returns from 2019 through
the current period. Our policy is to account for income tax related interest and penalties in income tax expense in the statement of
operations.
For
the three and nine months ended September 30, 2025 and 2024, the Company did not incur any interest and penalties associated with tax
positions. As of September 30, 2025, the Company did not have any significant unrecognized uncertain tax positions.
Note
8. Subsequent Event – Business Combination
The
Company entered into a stock purchase agreement (the “Purchase Agreement”) dated September 15, 2025, among the Company, Arps,
and the shareholders of Arps (the “Arps Shareholders”). On October 3, 2025, the Company, Arps and the Arps Shareholders completed
the closing under the Purchase Agreement. As a result, Arps became a wholly-owned subsidiary of the Company.
The
Company repaid approximately $ 1.3
million of certain existing debt of Arps, including an asset-based revolving facility, and is in the process of refinancing a $ 2.2
million mortgage loan (the “Mortgage”). The Company utilized a portion of its secured receivables financing facility, which had been recently
increased to $ 2.5
million, to effect the debt repayment. To obtain the forbearance agreement from the existing mortgage lender, the Company provided
its guaranty of the Mortgage loan and issued restricted shares of its common stock, valued at $ 100,000 ,
to the Arps Shareholders in exchange for continuing their guarantees with the mortgage lender. Prior to the closing, the Arps
Shareholders reduced the outstanding balance of the revolving facility as required by the Purchase Agreement. The Company and Arps
have agreed to repay the advances made by the Arps Shareholders within six months of the Closing, secured by a second mortgage on
real estate owned by Arps.
13
Arps,
which currently operates a dairy processing facility in Defiance, Ohio, had commenced construction on a 44,000 -square foot new facility
but was unable to complete construction. The Company plans to complete construction and installation of the processing equipment in the
new facility in 2026 (the “New Facility”). In October 2025, the Company incurred additional lease financing of $ 245,000 to
procure equipment.
The
Company has commenced manufacturing of certain of its own products at Arps’ existing facility and expects to expand production
during the fourth quarter of 2025 and into 2026, thereby eliminating fees previously
paid to third-party manufacturers, reducing freight costs, enabling the more efficient procurement of ingredients, and lowering cold
storage costs.
To
obtain the forbearance from Arps’ existing mortgage lender, WesBanco Bank, Inc., until January 1, 2026, the Company provided its
guaranty of the Mortgage loan. The outstanding balance of the Mortgage was $ 2,198,000 as of October 3, 2025.
Concurrently
with the Company’s acquisition of Arps, certain advances to Arps from its former shareholders were formalized with the Company
assuming joint and several responsibility for the obligations. The Company and Arps issued notes in the aggregate principal amount of
$ 800,000 to the Arps Shareholders, which consisted of $ 400,000 of debt previously owed by Arps (the “Existing Loans”) and
$ 400,000 representing the recent advances used to reduce the outstanding balance of the revolving facility (the “New Advances”).
The Existing Loans are to be repaid by April 3, 2026 and may be convertible into shares of the Company’s common stock at the option
of the Company, using the 15-day volume-weighted average trading price to determine the value of the shares. If the New Advances are
not paid by January 3, 2026, interest shall accrue at the rate of 7 % per annum from October 3, 2025.
Note
9. Liquidity
During
the nine months ended September 30, 2025, the Company used $ 2,173,000 in operations. As of September 30, 2025, the Company had $ 1,626,000
in working capital, including $ 1,891,000 in cash. As a result of the Arps acquisition (Note 8), the Company has assumed a $ 2,198,000
Mortgage that must be refinanced by January 1, 2026. Additionally, the Company has obligations outstanding under finance agreements of
$ 841,000 , including $ 245,000 borrowed in October 2025.
The
Company has a history of operating losses and negative cash flow, which are expected to improve with growth. As described more fully
in Note 4, the dispute and subsequent contract termination with the Manufacturer has resulted in limitations in the Company’s ability
to procure certain products necessary to achieve our growth projections and in elevated legal costs.
To
mitigate the impact of procurement constraints, the Company builds inventory in anticipation of third quarter seasonal requirements,
and has invested in materials necessary to carry out trials and initial production runs at new co-manufacturers and acquired Arps in
October 2025. The Company has an available receivables-based line of credit of $ 2,500,000 , with $ 1,759,000 in outstanding borrowing as
of September 30, 2025. Management expects that the cash cycle will shorten as additional contracted and owned capacity improves production
volume and efficiency in the fourth quarter of 2025 and beyond. Additionally, in May 2024, the Company obtained non-recourse litigation
financing to allow vigorous pursuit of the complaint against the Manufacturer without further expense to the Company. Finally, as described
in Note 6, the Company raised $ 3,000,000 through the sale of the Company’s common stock in February 2025.
The
financial position at September 30, 2025, historical results and obligations incurred in association with the Arps acquisition raise
substantial doubt about the Company’s ability to continue as a going concern. As described, the Company has completed steps to
mitigate dispute related issues and raise capital. The Company is undertaking steps to refinance the Mortgage on a long-term basis
and complete construction of the New Facility. The actions taken have resulted in the alleviation of the substantial doubt about the
Company’s ability to continue as a going concern.
14
Text extracted from the filing as submitted to EDGAR. Formatting, tables and exhibits are simplified for reading; the original document is authoritative for anything you rely on.